Plan B Decision Expected In Coming Weeks – Barr CEO
This article was originally published in The Tan Sheet
Barr Labs anticipates OTC approval of its Plan B emergency contraceptive "in the following weeks," according to CEO Bruce Downey
You may also be interested in...
FDA will deliver a decision in the "near future" on whether the Plan B emergency contraceptive pill is "approvable" for over-the-counter use in women age 16 and up, according to manufacturer Barr Labs
An FDA decision on the Rx-to-OTC switch of emergency contraceptive Plan B (levonorgestrel .75 mg) has been pushed back from February 20 to May 20
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC